Your browser doesn't support javascript.
loading
Preface to the special issue "Psychedelics and Neurochemistry".
Nichols, Charles D; Nichols, David E.
Affiliation
  • Nichols CD; Department of Pharmacology and Experimental Therapeutics, LSU Health Sciences Center, New Orleans, Louisiana, USA.
  • Nichols DE; Department of Medical Chemistry & Molecular Pharmacology, Purdue University, West Lafayette, Indiana, USA.
J Neurochem ; 162(1): 7-8, 2022 07.
Article in En | MEDLINE | ID: mdl-35699130
ABSTRACT
Psychedelics are a relatively recent field of research that had not gained much support half a century ago, yet it developed into a much acknowledged, highly relevant field that extends to many people's lives. Psychedelics have demonstrated profound and durable therapeutic potential for the treatment of several psychiatric disorders including depression, anxiety, and substance use disorders, among others. In this special issue, basic science of psychedelics is reviewed with respect to fundamental cellular, molecular, and genetic mechanisms, all the way up to the human systems level with clinical reviews. We hope the articles, authored by leading scientists in their field, will help to understand better the role of the serotonin 5-HT2A receptor in particular in healthy and diseased brain function.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Substance-Related Disorders / Hallucinogens / Neurochemistry Limits: Humans Language: En Journal: J Neurochem Year: 2022 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Substance-Related Disorders / Hallucinogens / Neurochemistry Limits: Humans Language: En Journal: J Neurochem Year: 2022 Document type: Article Affiliation country: United States
...